These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 33631273)
1. INPP5D expression is associated with risk for Alzheimer's disease and induced by plaque-associated microglia. Tsai AP; Lin PB; Dong C; Moutinho M; Casali BT; Liu Y; Lamb BT; Landreth GE; Oblak AL; Nho K Neurobiol Dis; 2021 Jun; 153():105303. PubMed ID: 33631273 [TBL] [Abstract][Full Text] [Related]
2. Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease. Castranio EL; Hasel P; Haure-Mirande JV; Ramirez Jimenez AV; Hamilton BW; Kim RD; Glabe CG; Wang M; Zhang B; Gandy S; Liddelow SA; Ehrlich ME Alzheimers Dement; 2023 Jun; 19(6):2239-2252. PubMed ID: 36448627 [TBL] [Abstract][Full Text] [Related]
3. The Alzheimer's disease risk factor INPP5D restricts neuroprotective microglial responses in amyloid beta-mediated pathology. Samuels JD; Moore KA; Ennerfelt HE; Johnson AM; Walsh AE; Price RJ; Lukens JR Alzheimers Dement; 2023 Nov; 19(11):4908-4921. PubMed ID: 37061460 [TBL] [Abstract][Full Text] [Related]
4. PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer's disease. Tsai AP; Dong C; Lin PB; Messenger EJ; Casali BT; Moutinho M; Liu Y; Oblak AL; Lamb BT; Landreth GE; Bissel SJ; Nho K Genome Med; 2022 Feb; 14(1):17. PubMed ID: 35180881 [TBL] [Abstract][Full Text] [Related]
5. INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease. Lin PB; Tsai AP; Soni D; Lee-Gosselin A; Moutinho M; Puntambekar SS; Landreth GE; Lamb BT; Oblak AL Alzheimers Dement; 2023 Jun; 19(6):2528-2537. PubMed ID: 36524682 [TBL] [Abstract][Full Text] [Related]
14. Expression of Zajac DJ; Simpson J; Zhang E; Parikh I; Estus S Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36981033 [TBL] [Abstract][Full Text] [Related]
15. Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression. Ando K; Küçükali F; Doeraene E; Nagaraj S; Antonelli EM; Thazin Htut M; Yilmaz Z; Kosa AC; Lopez-Guitierrez L; Quintanilla-Sánchez C; Aydin E; Ramos AR; Mansour S; Turbant S; Schurmans S; Sleegers K; Erneux C; Brion JP; Leroy K; Acta Neuropathol; 2024 Jun; 147(1):94. PubMed ID: 38833073 [TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice. Eskandari-Sedighi G; Crichton M; Zia S; Gomez-Cardona E; Cortez LM; Patel ZH; Takahashi-Yamashiro K; St Laurent CD; Sidhu G; Sarkar S; Aghanya V; Sim VL; Tan Q; Julien O; Plemel JR; Macauley MS Mol Neurodegener; 2024 May; 19(1):42. PubMed ID: 38802940 [TBL] [Abstract][Full Text] [Related]
17. SHIP1 modulation and proteome characterization of microglia. Ahat E; Shi Z; Chu S; Bui HH; Mason ER; Soni DM; Roth KD; Chalmers MJ; Oblak AL; Zhang J; Gutierrez JA; Richardson T J Proteomics; 2024 Jun; 302():105198. PubMed ID: 38777089 [TBL] [Abstract][Full Text] [Related]
18. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease. Sosna J; Philipp S; Albay R; Reyes-Ruiz JM; Baglietto-Vargas D; LaFerla FM; Glabe CG Mol Neurodegener; 2018 Mar; 13(1):11. PubMed ID: 29490706 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of REV-ERBs stimulates microglial amyloid-beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer's disease. Lee J; Kim DE; Griffin P; Sheehan PW; Kim DH; Musiek ES; Yoon SY Aging Cell; 2020 Feb; 19(2):e13078. PubMed ID: 31800167 [TBL] [Abstract][Full Text] [Related]
20. Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease. Yin Z; Raj D; Saiepour N; Van Dam D; Brouwer N; Holtman IR; Eggen BJL; Möller T; Tamm JA; Abdourahman A; Hol EM; Kamphuis W; Bayer TA; De Deyn PP; Boddeke E Neurobiol Aging; 2017 Jul; 55():115-122. PubMed ID: 28434692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]